These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12548077

  • 1. Differences between angiotensin-converting enzyme inhibition and angiotensin II-AT1 antagonism on angiotensin-mediated responses in human internal mammary arteries.
    Voors AA, Oosterga M, Buikema H, Mariani M, Grandjean JG, van Gilst WH.
    J Cardiovasc Pharmacol; 2003 Feb; 41(2):178-84. PubMed ID: 12548077
    [Abstract] [Full Text] [Related]

  • 2. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
    Richard V, Hurel-Merle S, Scalbert E, Ferry G, Lallemand F, Bessou JP, Thuillez C.
    Circulation; 2001 Aug 14; 104(7):750-2. PubMed ID: 11502696
    [Abstract] [Full Text] [Related]

  • 3. Dual pathway for angiotensin II formation in human internal mammary arteries.
    Voors AA, Pinto YM, Buikema H, Urata H, Oosterga M, Rooks G, Grandjean JG, Ganten D, van Gilst WH.
    Br J Pharmacol; 1998 Nov 14; 125(5):1028-32. PubMed ID: 9846641
    [Abstract] [Full Text] [Related]

  • 4. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
    MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH.
    Cardiovasc Res; 1999 Nov 14; 44(2):407-15. PubMed ID: 10690317
    [Abstract] [Full Text] [Related]

  • 5. Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
    McDonald JE, Padmanabhan N, Petrie MC, Hillier C, Connell JM, McMurray JJ.
    Circulation; 2001 Oct 09; 104(15):1805-8. PubMed ID: 11591618
    [Abstract] [Full Text] [Related]

  • 6. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B, de Vries R, Saxena PR, Danser AH.
    Hypertension; 2001 Jul 09; 38(1):95-9. PubMed ID: 11463767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 9. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP, Ennezat PV, Lisker J, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH.
    Circulation; 2000 Feb 29; 101(8):844-6. PubMed ID: 10694521
    [Abstract] [Full Text] [Related]

  • 10. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1997 Feb 29; 29(2):813-22. PubMed ID: 9140837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system.
    Nishimura H, Buikema H, Baltatu O, Ganten D, Urata H.
    Am J Physiol; 1998 Oct 29; 275(4):H1307-12. PubMed ID: 9746480
    [Abstract] [Full Text] [Related]

  • 13. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F, Al-Jarallah A, Joseph S.
    PLoS One; 2016 Oct 29; 11(11):e0165777. PubMed ID: 27814397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
    Padmanabhan N, Jardine AG, McGrath JC, Connell JM.
    Circulation; 1999 Jun 08; 99(22):2914-20. PubMed ID: 10359736
    [Abstract] [Full Text] [Related]

  • 18. ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles.
    Marchetti J, Helou CM, Chollet C, Rajerison R, Alhenc-Gelas F.
    Am J Physiol Heart Circ Physiol; 2003 Jun 08; 284(6):H1933-41. PubMed ID: 12586636
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.
    J Cardiovasc Pharmacol; 2001 Jul 08; 38(1):141-8. PubMed ID: 11444497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.